1
|
Camacho PM, Dayal AS, Diaz JL, Nabhan FA, Agarwal M, Norton JG, Robinson PA, Albain KS. Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis. J Clin Oncol 2008; 26:5380-5. [DOI: 10.1200/jco.2008.17.7451] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PurposeTo determine the prevalence of secondary causes of bone loss among patients with breast cancer with osteopenia and osteoporosis.Patients and MethodsAll women referred to a bone health clinic over a 6-year period for bone evaluation were included in this retrospective study and stratified based on presence or absence of a breast cancer history. The prevalence of secondary causes of bone loss in the two groups was compared.ResultsOf the 238 women identified, 64 women had breast cancer. The non–breast cancer group (n = 174) was significantly older (P = .015), had a lower mean weight (P = .019), lower 25 hydroxy-vitamin D level (P = .019), and greater degree of bone loss in both the spine and hip (P < .001 and 0.004, respectively). The presence of at least one secondary cause of bone loss, excluding cancer-related therapies, was seen in 78% of the breast cancer patient group and in 77% of the non–breast cancer group (P = not significant). Newly diagnosed metabolic bone disorders were seen in 58% of the breast cancer population. The most common was vitamin D deficiency, seen in 38% of patients in the breast cancer group and 51% of patients in the non–breast cancer group. Idiopathic hypercalciuria was diagnosed in 15.6%, primary hyperparathyroidism in 1.6%, and normocalcemic hyperparathyroidism in 3.1% of the breast cancer population.ConclusionA high prevalence of secondary causes of bone loss among patients with breast cancer supports a comprehensive evaluation in these patients, particularly those considering therapy with an aromatase inhibitor.
Collapse
Affiliation(s)
- Pauline M. Camacho
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Amit S. Dayal
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Josefina L. Diaz
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Fadi A. Nabhan
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Monica Agarwal
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - John G. Norton
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Patricia A. Robinson
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| | - Kathy S. Albain
- From the Divisions of Endocrinology and Metabolism, Hematology/Oncology Institute, and Department of Medicine, Loyola University Medical Center, Maywood, IL
| |
Collapse
|
2
|
Schoppmann SF, Jakesz R. Early-Stage Breast Cancer – Highlights at ASCO 2006. Breast Care (Basel) 2006. [DOI: 10.1159/000094712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|